Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Multiple Myeloma 43Prostatic Neoplasms 41Carcinoma, Non-Small-Cell Lung 36Breast Neoplasms 34Lymphoma 28Leukemia, Myeloid, Acute 25Lymphoma, Non-Hodgkin 21Melanoma 18Colorectal Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Ovarian Neoplasms 15Lung Neoplasms 15Hodgkin Disease 15Hematologic Neoplasms 15Squamous Cell Carcinoma of Head and Neck 13Neoplasms 13Neoplasm Metastasis 13Myelodysplastic Syndromes 13Sarcoma 12Leukemia, Lymphocytic, Chronic, B-Cell 12Wilms Tumor 11Head and Neck Neoplasms 11Carcinoma, Renal Cell 11Burkitt Lymphoma 11Triple Negative Breast Neoplasms 10Pancreatic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 9Leukemia 9Glioma 9Fallopian Tube Neoplasms 9

Interventions

nilotinib 1Paclitaxel 1Laparoscopy 1Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Genital Neoplasms, Female × 30 days × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡